Bridgebio Pharma, Inc. · NASDAQ:BBIO
Janus Henderson Group PLC reported a 6.80% stake in Bridgebio Pharma, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Janus Henderson Group PLC reported a 6.80% stake in Bridgebio Pharma, Inc., 13,179,013 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 13,179,013
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.80% | 13,179,013 |
Source
Related
- Bridgebio Pharma, Inc.
- Janus Henderson Group PLC
- Bridgebio Pharma, Inc. shareholders
- Schedule 13G · Janus Henderson Group PLC · Feb 17, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Trimarchi Thomas · Aug 18, 2026
- Form 4 · Apuli Maricel · Aug 18, 2026